Načítá se...
DDIS-04. NITROXOLINE EXHIBIT ANTICANCER ACTIVITY INDUCING APOPTOSIS IN A TEMOZOLOMIDE-RESISTANT GLIOBLASTOMA
Glioblastoma multiforme (GBM) is one of the most aggressive human tumors with poor survival. Current standard treatment includes chemotherapy with DNA-alkylating agent temozolomide (TMZ), but the acquisition of resistance is a persistent clinical problem limiting the successful treatment of GBM. In...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691912/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.240 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|